Skip to main content
Fig. 3 | World Journal of Surgical Oncology

Fig. 3

From: Esophageal squamous cell carcinoma with EP300 mutations displays distinct genetic characteristics relevant to neoadjuvant chemoradiotherapy

Fig. 3

Differentially expressed immune-related genes and gene ontology (GO) analyses between the three groups. (A) Cluster analyses of differentially expressed immune-related genes between the EP300-mutated and wild-type poor response groups. (B) GO analyses show the differences in immune-related biological process (BP) between EP300-mutated and wild-type poor response groups. (C) Cluster analyses of differentially expressed immune-related genes between the EP300 wild-type well response and poor response groups. (D) GO analyses show the differences in immune-related BP between EP300 wild-type well response and poor response groups. (E) Cluster analyses of differentially expressed immune-related genes between the EP300-mutated poor response and EP300 wild-type well response groups. (F) GO analyses show nonimmune-related BP and molecular function between the EP300-mutated poor response and EP300 wild-type well response groups

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us